ATE136776T1 - Verwendung von heptastigmin zur behandlung der zerebralen ictus - Google Patents
Verwendung von heptastigmin zur behandlung der zerebralen ictusInfo
- Publication number
- ATE136776T1 ATE136776T1 AT91121676T AT91121676T ATE136776T1 AT E136776 T1 ATE136776 T1 AT E136776T1 AT 91121676 T AT91121676 T AT 91121676T AT 91121676 T AT91121676 T AT 91121676T AT E136776 T1 ATE136776 T1 AT E136776T1
- Authority
- AT
- Austria
- Prior art keywords
- heptastigmine
- treat cerebral
- ictus
- cerebral ictus
- treat
- Prior art date
Links
- RRGMXBQMCUKRLH-CTNGQTDRSA-N [(3ar,8bs)-3,4,8b-trimethyl-2,3a-dihydro-1h-pyrrolo[2,3-b]indol-7-yl] n-heptylcarbamate Chemical compound C12=CC(OC(=O)NCCCCCCC)=CC=C2N(C)[C@@H]2[C@@]1(C)CCN2C RRGMXBQMCUKRLH-CTNGQTDRSA-N 0.000 title abstract 2
- 230000002490 cerebral effect Effects 0.000 title abstract 2
- 230000003727 cerebral blood flow Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT02251390A IT1246050B (it) | 1990-12-21 | 1990-12-21 | Impiego dell'eptastigmina nella terapia dell'ictus cerebrale. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE136776T1 true ATE136776T1 (de) | 1996-05-15 |
Family
ID=11197279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91121676T ATE136776T1 (de) | 1990-12-21 | 1991-12-18 | Verwendung von heptastigmin zur behandlung der zerebralen ictus |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0492383B1 (de) |
| JP (1) | JPH04308529A (de) |
| KR (1) | KR920011482A (de) |
| AT (1) | ATE136776T1 (de) |
| CA (1) | CA2058228A1 (de) |
| DE (1) | DE69118847T2 (de) |
| ES (1) | ES2085411T3 (de) |
| IE (1) | IE914463A1 (de) |
| IT (1) | IT1246050B (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100908068B1 (ko) * | 2008-12-31 | 2009-07-15 | 주식회사 비케이티 | 대리석 석판, 대리석 석판 가공장치 및 그 가공방법 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1199076B (it) * | 1984-03-01 | 1988-12-30 | Consiglio Nazionale Ricerche | Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione |
-
1990
- 1990-12-21 IT IT02251390A patent/IT1246050B/it active IP Right Grant
-
1991
- 1991-12-18 ES ES91121676T patent/ES2085411T3/es not_active Expired - Lifetime
- 1991-12-18 EP EP91121676A patent/EP0492383B1/de not_active Expired - Lifetime
- 1991-12-18 AT AT91121676T patent/ATE136776T1/de active
- 1991-12-18 DE DE69118847T patent/DE69118847T2/de not_active Expired - Fee Related
- 1991-12-19 IE IE446391A patent/IE914463A1/en not_active Application Discontinuation
- 1991-12-20 JP JP3354447A patent/JPH04308529A/ja active Pending
- 1991-12-20 KR KR1019910023605A patent/KR920011482A/ko not_active Withdrawn
- 1991-12-20 CA CA002058228A patent/CA2058228A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IT1246050B (it) | 1994-11-07 |
| JPH04308529A (ja) | 1992-10-30 |
| KR920011482A (ko) | 1992-07-24 |
| IE914463A1 (en) | 1992-07-01 |
| EP0492383A1 (de) | 1992-07-01 |
| IT9022513A0 (it) | 1990-12-21 |
| IT9022513A1 (it) | 1992-06-21 |
| CA2058228A1 (en) | 1992-06-22 |
| DE69118847T2 (de) | 1996-09-05 |
| DE69118847D1 (de) | 1996-05-23 |
| ES2085411T3 (es) | 1996-06-01 |
| EP0492383B1 (de) | 1996-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE184792T1 (de) | 2-bromomelatonin zur behandlung von schlafstörungen | |
| DE3684190D1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
| DE3856594D1 (de) | Mittel zur behandlung der alzheimer-krankheit | |
| ATE254926T1 (de) | Verwendung eines consensus-interferons zur reduzierung der nebeneffekte in der interferon behandlung von viralen hepatiten. | |
| BG60253B1 (bg) | Човешки тъканен плазминогенен активатор | |
| DE69124293D1 (de) | Vorrichtung zur Behandlung von Wirbelsäulenerkrankungen | |
| DE58902094D1 (de) | Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen. | |
| ATE73663T1 (de) | Phosphonylmethoxyalkyl-adeninen zur behandlung von viruskrankheiten. | |
| ATE67666T1 (de) | Verwendung von sulfomucopolysacchariden zur therapeutischen behandlung von krankheiten des alzheimertyps. | |
| DE3582439D1 (de) | Mittel zur behandlung von herzerkrankungen. | |
| ATE137965T1 (de) | Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege | |
| ATE174798T1 (de) | Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation | |
| DE3854121D1 (de) | Arzneimittelzusammensetzungen zur behandlung von psoriasis. | |
| ATE106736T1 (de) | Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes. | |
| ATE89737T1 (de) | Behandlung von leukozytstoerungen mit gm-csf. | |
| ATE222491T1 (de) | Melatonin-derivate zur verwendung in der behandlung von schlafstörungen | |
| ATE239470T1 (de) | Melatonin-derivate zur verwendung in der behandlung von desynchronisierungs-erkankungen | |
| ATE74762T1 (de) | Pharmazeutisches praeparat zur behandlung von stoerungen des fettstoffwechsels (hyperlipoproteinaemien). | |
| DE69313261D1 (de) | Verwendung von LACTOFERRIN zur Herstellung eines THERAPEUTISCHEN MITTELS zur Behandlung von RHEUMATISMUS | |
| ATE59780T1 (de) | Pharmazeutische zusammensetzung zur behandlung von tumoren. | |
| ATE5256T1 (de) | Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel. | |
| ATE45675T1 (de) | Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen. | |
| ATE136776T1 (de) | Verwendung von heptastigmin zur behandlung der zerebralen ictus | |
| ATE229343T1 (de) | Kombination von temozolomide und alpha-interferon zur behandlung von fortgeschrittenem krebs | |
| DE59410340D1 (de) | Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen |